BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6548864)

  • 21. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK; Lyles KW; Haussler MR; Harrelson JM
    J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcitriol treatment in vitamin D-dependent and vitamin D-resistant rickets.
    Glorieux FH
    Metabolism; 1990 Apr; 39(4 Suppl 1):10-2. PubMed ID: 2157942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hereditary hypophosphatemic rickets with hypercalciuria: case report.
    Areses-Trapote R; López-García JA; Ubetagoyena-Arrieta M; Eizaguirre A; Sáez-Villaverde R
    Nefrologia; 2012 Jul; 32(4):529-34. PubMed ID: 22806288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of 1,25-dihydroxyvitamin D3 treatment on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice.
    Ecarot B; Glorieux FH; Desbarats M; Travers R; Labelle L
    J Bone Miner Res; 1995 Mar; 10(3):424-31. PubMed ID: 7785464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum parathyroid hormone in hypophosphatemic vitamin D-resistant rickets.
    Lewy JE; Cabana EC; Repetto HA; Canterbury JM; Reiss E
    J Pediatr; 1972 Aug; 81(2):294-300. PubMed ID: 4339535
    [No Abstract]   [Full Text] [Related]  

  • 26. [Early diagnosis and early treatment of hypophosphatemic vitamin D-resistant rickets].
    Schaumberger E; Hohenauer L; Sommer R
    Klin Padiatr; 1986; 198(1):44-8. PubMed ID: 3007858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [X-linked familial hypophosphatemic rickets report of six cases (author's transl)].
    de Castro P; Collado F; Torreblanca J
    An Esp Pediatr; 1979 Mar; 12(3):189-98. PubMed ID: 443639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Renal phosphate leak, rickets and hypercalciuria--a new hereditary syndrome].
    Samuel R; Arie R; Liberman UA; Modai D; Tieder M
    Harefuah; 1988 Feb; 114(3):105-9. PubMed ID: 3350423
    [No Abstract]   [Full Text] [Related]  

  • 29. The common marmoset as an animal model for vitamin D-dependent rickets, type II.
    Suda T; Takahashi N; Shinki T; Yamaguchi A; Tanioka Y
    Adv Exp Med Biol; 1986; 196():423-35. PubMed ID: 3012983
    [No Abstract]   [Full Text] [Related]  

  • 30. "Idiopathic" hypercalciuria and hereditary hypophosphatemic rickets. Two phenotypical expressions of a common genetic defect.
    Tieder M; Modai D; Shaked U; Samuel R; Arie R; Halabe A; Maor J; Weissgarten J; Averbukh Z; Cohen N
    N Engl J Med; 1987 Jan; 316(3):125-9. PubMed ID: 3796683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypercalciuric rickets: metabolic studies and pathophysiological considerations.
    Tieder M; Samuel R; Liberman UA; Arie R; Halabe A; Gabizon D; Maor Y; Halperin N; Capeliovitch L; Modai D
    Nephron; 1985; 39(3):194-200. PubMed ID: 2983252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute biochemical effects of growth hormone treatment compared with conventional treatment in familial hypophosphataemic rickets.
    Patel L; Clayton PE; Brain C; Pelekouda E; Addison GM; Price DA; Mughal MZ
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):687-96. PubMed ID: 8759181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D metabolism in hypophosphatemic vitamin D-resistant rickets.
    Seino Y; Shimotsuji T; Ishida M; Ishii T; Yamaoka K; Yabuuchi H
    Contrib Nephrol; 1980; 22():101-6. PubMed ID: 6249540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nocturnal hyperparathyroidism: a frequent feature of X-linked hypophosphatemia.
    Carpenter TO; Mitnick MA; Ellison A; Smith C; Insogna KL
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1378-83. PubMed ID: 8200940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Humoral abnormalities in X-linked hypophosphatemic mice.
    Meyer RA
    Nephron; 1989; 53(4):293-6. PubMed ID: 2689897
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets.
    Chesney RW; Mazess RB; Rose P; Hamstra AJ; DeLuca HF; Breed AL
    Pediatrics; 1983 Apr; 71(4):559-67. PubMed ID: 6300745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased intestinal absorption of calcium in young and adult X-linked hypophosphatemic mice after the administration of 1,25-dihydroxyvitamin D3.
    Meyer MH; Meyer RA
    J Bone Miner Res; 1988 Apr; 3(2):151-7. PubMed ID: 3213610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parathyroid hormone secretion in familial vitamin-D-resistant rickets.
    Reitz RE; Weinstein RL
    N Engl J Med; 1973 Nov; 289(18):941-5. PubMed ID: 4355232
    [No Abstract]   [Full Text] [Related]  

  • 39. Prenatal diagnosis of vitamin D-dependent rickets, type II: response to 1,25-dihydroxyvitamin D in amniotic fluid cells and fetal tissues.
    Weisman Y; Jaccard N; Legum C; Spirer Z; Yedwab G; Even L; Edelstein S; Kaye AM; Hochberg Z
    J Clin Endocrinol Metab; 1990 Oct; 71(4):937-43. PubMed ID: 2169482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteocalcin abnormalities in Hyp mice reflect altered genetic expression and are not due to altered clearance, affinity for mineral, or ambient phosphorus levels.
    Carpenter TO; Gundberg CM
    Endocrinology; 1996 Dec; 137(12):5213-9. PubMed ID: 8940337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.